Cargando…

Chemopreventive Effects of Concomitant or Individual Use of Statins, Aspirin, Metformin, and Angiotensin Drugs: A Study Using Claims Data of 23 Million Individuals

SIMPLE SUMMARY: Medications for chronic diseases, such as tatins, aspirin, metformin, and angiotensin-converting-enzyme inhibitors/angiotensin II receptor blockers, are studied for decades, and a vast body of previous research has suggested potential repurposing of these medications for cancer preve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ching-Huan, Huang, Chih-Wei, Nguyen, Phung Anh, Lin, Ming-Chin, Yeh, Chih-Yang, Islam, Md. Mohaimenul, Rahmanti, Annisa Ristya, Yang, Hsuan-Chia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909564/ https://www.ncbi.nlm.nih.gov/pubmed/35267516 http://dx.doi.org/10.3390/cancers14051211

Ejemplares similares

How Can Research on Artificial Empathy Be Enhanced by Applying Deepfakes?
por: Yang, Hsuan-Chia, et al.
Publicado: (2022)

Association between Statin Use and Risk of Parkinson’s Disease: Evidence from 18 Observational Studies Comprising 3.7 Million Individuals
por: Wu, Chieh-Chen, et al.
Publicado: (2022)

Renin-Angiotensin-Aldosterone System Inhibitors and Development of Gynecologic Cancers: A 23 Million Individual Population-Based Study
por: Nguyen, Nhi Thi Hong, et al.
Publicado: (2023)

Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?
por: Goh, Myung Ji, et al.
Publicado: (2022)

Social Media Data Analytics for Outbreak Risk Communication: Public Attention on the “New Normal” During the COVID-19 Pandemic in Indonesia
por: Rahmanti, Annisa Ristya, et al.
Publicado: (2021)

Associations of aspirin, statins and metformin with lung cancer risk and related mortality
por: Frille, Armin, et al.
Publicado: (2021)

SlimMe, a Chatbot With Artificial Empathy for Personal Weight Management: System Design and Finding
por: Rahmanti, Annisa Ristya, et al.
Publicado: (2022)

Social media sentiment analysis to monitor the performance of vaccination coverage during the early phase of the national COVID-19 vaccine rollout
por: Rahmanti, Annisa Ristya, et al.
Publicado: (2022)

Potentiating the effects of radiotherapy in rectal cancer: the role of aspirin, statins and metformin as adjuncts to therapy
por: Gash, K J, et al.
Publicado: (2017)

Population-wide impacts of aspirin, statins, and metformin use on prostate cancer incidence and mortality
por: Koo, Hye Yeon, et al.
Publicado: (2021)

Uncovering the mechanism of action of aspirin in HCC chemoprevention
por: Roehlen, Natascha, et al.
Publicado: (2019)

Colorectal cancer chemoprevention: is aspirin still in the game?
por: Grancher, Adrien, et al.
Publicado: (2022)

Potential Benefits of Combined Statin and Metformin Therapy on Resistance Training Response in Older Individuals
por: Long, Douglas E., et al.
Publicado: (2022)

3437 Associations of aspirin, non-aspirin NSAIDs, statins, and metformin with risk of biliary cancer: A Swedish population-based cohort study
por: Bonilla, Lorena Marcano, et al.
Publicado: (2019)

Gastroprotective [6]-Gingerol Aspirinate as a Novel Chemopreventive Prodrug of Aspirin for Colon Cancer
por: Zhu, Yingdong, et al.
Publicado: (2017)

Association between Proton Pump Inhibitor Use and the Risk of Female Cancers: A Nested Case-Control Study of 23 Million Individuals
por: Nguyen, Nhi Thi Hong, et al.
Publicado: (2022)

The effect of concomitant use of statins, NSAIDs, low-dose aspirin, metformin and beta-blockers on outcomes in patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis
por: Zhang, Yongchao, et al.
Publicado: (2021)

Individual and joint effects of metformin and statins on mortality among patients with high‐risk prostate cancer
por: Tan, Xiang‐Lin, et al.
Publicado: (2020)

Proton Pump Inhibitors Use and the Risk of Pancreatic Cancer: Evidence from Eleven Epidemiological Studies, Comprising 1.5 Million Individuals
por: Poly, Tahmina Nasrin, et al.
Publicado: (2022)

Chemopreventive Effect of Metformin on Gastric Cancer Development
por: Cheung, Ka Shing, et al.
Publicado: (2022)

Effect of Statins, Metformin, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin II Receptor Blockers on Age-Related Macular Degeneration
por: Lee, Hyesung, et al.
Publicado: (2019)

Aspirin‐based chemoprevention of colorectal cancer: The role for gut microbiota
por: Diao, Feiyu, et al.
Publicado: (2020)

Chemoprevention by aspirin against inflammation-related colorectal cancer in mice
por: Ohnishi, Shiho, et al.
Publicado: (2021)

Scaling computational genomics to millions of individuals with GPUs
por: Taylor-Weiner, Amaro, et al.
Publicado: (2019)

Emergence of aspirin as a promising chemopreventive and chemotherapeutic agent for liver cancer
por: Xia, Hongping, et al.
Publicado: (2017)

Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study
por: Löfling, L. Lukas, et al.
Publicado: (2023)

Metformin, Statin Use, and Female Colorectal Cancer: A Population-Based Cohort Study in Taiwan
por: Hsu, Shu-Hua, et al.
Publicado: (2022)

Voice-based control system for smart hospital wards: a pilot study of patient acceptance
por: Jian, Wen-Shan, et al.
Publicado: (2022)

Aspirin and Statin Use and the Risk of Gallbladder Cancer
por: Prasai, Kritika, et al.
Publicado: (2021)

Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?
por: Zanders, M M J, et al.
Publicado: (2015)

Heart healthy equals prostate healthy and statins, aspirin, and/or metformin (S.A.M.) are the ideal recommendations for prostate cancer prevention
por: Moyad, Mark A, et al.
Publicado: (2015)

Breast Cancer Metabolism and Mitochondrial Activity: The Possibility of Chemoprevention with Metformin
por: Cazzaniga, Massimiliano, et al.
Publicado: (2015)

Metformin- A Promising Agent for Chemoprevention in BRCA1 Carriers
por: Kumar, Nagi B., et al.
Publicado: (2012)

Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
por: Ho, Cheng-Maw, et al.
Publicado: (2018)

The molecular mechanism of action of aspirin, curcumin and sulforaphane combinations in the chemoprevention of pancreatic cancer
por: THAKKAR, ARVIND, et al.
Publicado: (2013)

Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention
por: Ornelas, Argentina, et al.
Publicado: (2017)

Survival Analysis of 1140 Patients with Biliary Cancer and Benefit from Concurrent Renin-Angiotensin Antagonists, Statins, or Aspirin with Systemic Therapy
por: Gunchick, Valerie, et al.
Publicado: (2023)

Statin-Induced Myositis with Concomitant Myocarditis
por: Patail, Haris, et al.
Publicado: (2022)

The Concomitant Association of Thyroid Disorders and Myasthenia Gravis
por: Lin, Yu-Pei, et al.
Publicado: (2017)

Aspirin and statin therapy in sepsis, a red herring?
por: Campbell, R, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4h9lj4reg2eq4bt1blv8qsan51